189 related articles for article (PubMed ID: 36367013)
1. Tracking the progressive spread of the SARS-CoV-2 Omicron variant in Italy, December 2021 to January 2022.
Stefanelli P; Trentini F; Petrone D; Mammone A; Ambrosio L; Manica M; Guzzetta G; d'Andrea V; Marziano V; Zardini A; Molina Grane' C; Ajelli M; Di Martino A; Riccardo F; Bella A; Sane Schepisi M; Maraglino F; Poletti P; Palamara AT; Brusaferro S; Rezza G; Pezzotti P; Merler S; ; ; ;
Euro Surveill; 2022 Nov; 27(45):. PubMed ID: 36367013
[TBL] [Abstract][Full Text] [Related]
2. Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.
Iuliano AD; Brunkard JM; Boehmer TK; Peterson E; Adjei S; Binder AM; Cobb S; Graff P; Hidalgo P; Panaggio MJ; Rainey JJ; Rao P; Soetebier K; Wacaster S; Ai C; Gupta V; Molinari NM; Ritchey MD
MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):146-152. PubMed ID: 35085225
[TBL] [Abstract][Full Text] [Related]
3. Baseline Sequencing Surveillance of Public Clinical Testing, Hospitals, and Community Wastewater Reveals Rapid Emergence of SARS-CoV-2 Omicron Variant of Concern in Arizona, USA.
Smith MF; Holland SC; Lee MB; Hu JC; Pham NC; Sullins RA; Holland LA; Mu T; Thomas AW; Fitch R; Driver EM; Halden RU; Villegas-Gold M; Sanders S; Krauss JL; Nordstrom L; Mulrow M; White M; Murugan V; Lim ES
mBio; 2023 Feb; 14(1):e0310122. PubMed ID: 36622143
[TBL] [Abstract][Full Text] [Related]
4. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
[TBL] [Abstract][Full Text] [Related]
5. Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants - United States, June 2021-January 2022.
Lambrou AS; Shirk P; Steele MK; Paul P; Paden CR; Cadwell B; Reese HE; Aoki Y; Hassell N; Zheng XY; Talarico S; Chen JC; Oberste MS; Batra D; McMullan LK; Halpin AL; Galloway SE; MacCannell DR; Kondor R; Barnes J; MacNeil A; Silk BJ; Dugan VG; Scobie HM; Wentworth DE; Caravas J; Kovacs NA; Gerhart JG; Jia Ng H; Beck A; Chau R; Cintron R; Cook PW; Gulvik CA; Howard D; Jang Y; Knipe K; Lacek KA; Moser KA; Paskey AC; Rambo-Martin BL; Nagilla RR; Retchless AC; Schmerer MW; Seby S; Shepard SS; Stanton RA; Stark TJ; Uehara A; Unoarumhi Y; Bentz ML; Burgin A; Burroughs M; Davis ML; Keller MW; Keong LM; Le SS; Lee JS; Madden Jr JC; Nobles S; Owuor DC; Padilla J; Sheth M; Wilson MM; ;
MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):206-211. PubMed ID: 35143464
[TBL] [Abstract][Full Text] [Related]
6. Comparative severity of COVID-19 cases caused by Alpha, Delta or Omicron SARS-CoV-2 variants and its association with vaccination.
Varea-Jiménez E; Aznar Cano E; Vega-Piris L; Martínez Sánchez EV; Mazagatos C; García San Miguel Rodríguez-Alarcón L; Casas I; Sierra Moros MJ; Iglesias-Caballero M; Vazquez-Morón S; Larrauri A; Monge S;
Enferm Infecc Microbiol Clin (Engl Ed); 2024 Apr; 42(4):187-194. PubMed ID: 36737369
[TBL] [Abstract][Full Text] [Related]
7. Reduction of the risk of severe COVID-19 due to Omicron compared to Delta variant in Italy (November 2021 - February 2022).
Petrone D; Mateo-Urdiales A; Sacco C; Riccardo F; Bella A; Ambrosio L; Lo Presti A; Di Martino A; Ceccarelli E; Del Manso M; Fabiani M; Stefanelli P; Pezzotti P; Palamara A;
Int J Infect Dis; 2023 Apr; 129():135-141. PubMed ID: 36708869
[TBL] [Abstract][Full Text] [Related]
8. Comparison of clinical characteristics and outcomes of critically ill adults with SARS-CoV-2 infection during Delta and Omicron variant predominance periods: a single-hospital retrospective cohort study.
Sankar K; Modi N; Polyak A; Directo MP; Johnson LR; Kho N; Isonaka SK; Pedraza I; Chen P; Modes ME
BMJ Open Respir Res; 2023 Feb; 10(1):. PubMed ID: 36805880
[TBL] [Abstract][Full Text] [Related]
9. Epidemiological Characterization of Patients in the First Eight Weeks Following Detection of SARS-CoV-2 B.1.1.529 (omicron) Variant in Cuba.
Pérez-Santosa L; Kourí-Cardellá V; Tejero-Suárez Y; Macías-Roig LM; Pintos-Saavedra Y; Medero-Díaz D; Figueredo-Amador C; Naranjo-González C; Morales-Arredondo D; Tamayo-Pérez NE; Martínez-Montesino Y; López-Almaguer Y; de Armas-Fernández JR; Portal-Miranda JA; Guzmán-Tirado MG
MEDICC Rev; 2022 Oct; 24(3-4):18-23. PubMed ID: 36417330
[TBL] [Abstract][Full Text] [Related]
10. Rapid emergence of SARS-CoV-2 Omicron variant is associated with an infection advantage over Delta in vaccinated persons.
Chaguza C; Coppi A; Earnest R; Ferguson D; Kerantzas N; Warner F; Young HP; Breban MI; Billig K; Koch RT; Pham K; Kalinich CC; Ott IM; Fauver JR; Hahn AM; Tikhonova IR; Castaldi C; De Kumar B; Pettker CM; Warren JL; Weinberger DM; Landry ML; Peaper DR; Schulz W; Vogels CBF; Grubaugh ND
Med; 2022 May; 3(5):325-334.e4. PubMed ID: 35399324
[TBL] [Abstract][Full Text] [Related]
11. A Quick Displacement of the SARS-CoV-2 variant Delta with Omicron: Unprecedented Spike in COVID-19 Cases Associated with Fewer Admissions and Comparable Upper Respiratory Viral Loads.
Fall A; Eldesouki RE; Sachithanandham J; Morris CP; Norton JM; Gaston DC; Forman M; Abdullah O; Gallagher N; Li M; Swanson NJ; Pekosz A; Klein EY; Mostafa HH
medRxiv; 2022 Jan; ():. PubMed ID: 35118480
[TBL] [Abstract][Full Text] [Related]
12. Impact of SARS-CoV-2 Omicron and Delta variants in patients requiring intensive care unit (ICU) admission for COVID-19, Northern Italy, December 2021 to January 2022.
Piralla A; Mojoli F; Pellegrinelli L; Ceriotti F; Valzano A; Grasselli G; Gismondo MR; Micheli V; Castelli A; Farina C; Arosio M; Lorini FL; Fanti D; Busni A; Laratta M; Maggi F; Novazzi F; Cabrini L; Callegaro AP; Keim R; Remuzzi G; Cavallero A; Malandrin SMI; Rona R; Giardina F; Ferrari G; Zavaglio F; D'angelo P; Galli C; Bubba L; Binda S; Oggioni M; Uceda Renteria SC; Bono P; Baj A; Ferrante FD; Guarneri D; Tonelli M; Napolitano G; Nava A; Romeo L; Nicolini E; Valaperta R; Varisano L; Mele C; Liguori L; Raggi M; Mongodi S; Pagani M; Severgnini P; Gasberti D; Bonanomi E; Gritti P; Marrazzo F; Giovannini I; Sacchi N; Sagliocco O; Cereda D; Buoro S; Baldanti F; Pariani E
Respir Med Res; 2023 Jun; 83():100990. PubMed ID: 36871459
[TBL] [Abstract][Full Text] [Related]
13. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
[TBL] [Abstract][Full Text] [Related]
14. Relative instantaneous reproduction number of Omicron SARS-CoV-2 variant with respect to the Delta variant in Denmark.
Ito K; Piantham C; Nishiura H
J Med Virol; 2022 May; 94(5):2265-2268. PubMed ID: 34967453
[TBL] [Abstract][Full Text] [Related]
15. Retrospective analysis of SARS-CoV-2 omicron invasion over delta in French regions in 2021-22: a status-based multi-variant model.
Haschka T; Vergu E; Roche B; Poletto C; Opatowski L
BMC Infect Dis; 2022 Nov; 22(1):815. PubMed ID: 36324075
[TBL] [Abstract][Full Text] [Related]
16. The rapid spread of SARS-COV-2 Omicron variant in Italy reflected early through wastewater surveillance.
La Rosa G; Iaconelli M; Veneri C; Mancini P; Bonanno Ferraro G; Brandtner D; Lucentini L; Bonadonna L; Rossi M; Grigioni M; ; Suffredini E
Sci Total Environ; 2022 Sep; 837():155767. PubMed ID: 35533857
[TBL] [Abstract][Full Text] [Related]
17. Tracking Emergence and Spread of SARS-CoV-2 Omicron Variant in Large and Small Communities by Wastewater Monitoring in Alberta, Canada.
Hubert CRJ; Acosta N; Waddell BJM; Hasing ME; Qiu Y; Fuzzen M; Harper NBJ; Bautista MA; Gao T; Papparis C; Van Doorn J; Du K; Xiang K; Chan L; Vivas L; Pradhan P; McCalder J; Low K; England WE; Kuzma D; Conly J; Ryan MC; Achari G; Hu J; Cabaj JL; Sikora C; Svenson L; Zelyas N; Servos M; Meddings J; Hrudey SE; Frankowski K; Parkins MD; Pang XL; Lee BE
Emerg Infect Dis; 2022 Sep; 28(9):1770-1776. PubMed ID: 35867051
[TBL] [Abstract][Full Text] [Related]
18. Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA-Vaccinated and Nonvaccinated Individuals in Quebec, Canada.
Carazo S; Skowronski DM; Brisson M; Sauvageau C; Brousseau N; Gilca R; Ouakki M; Barkati S; Fafard J; Talbot D; Gilca V; Deceuninck G; Garenc C; Carignan A; De Wals P; De Serres G
JAMA Netw Open; 2022 Oct; 5(10):e2236670. PubMed ID: 36239934
[TBL] [Abstract][Full Text] [Related]
19. The Spread of SARS-CoV-2 Variant Omicron with a Doubling Time of 2.0-3.3 Days Can Be Explained by Immune Evasion.
Grabowski F; Kochańczyk M; Lipniacki T
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215887
[TBL] [Abstract][Full Text] [Related]
20. Estimation of Serial Interval and Reproduction Number to Quantify the Transmissibility of SARS-CoV-2 Omicron Variant in South Korea.
Kim D; Ali ST; Kim S; Jo J; Lim JS; Lee S; Ryu S
Viruses; 2022 Mar; 14(3):. PubMed ID: 35336939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
